COURTNEY TURK: Open Payments
NPI 1134152846 · GLASSBORO, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$769 in 44 payments from 18 companies in 2025. Trend: 2023 $804 · 2024 $994 · 2025 $769
Food & beverage: $769
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $153 |
| Novo Nordisk Inc | 5 | $86 |
| Astellas Pharma US Inc | 4 | $79 |
| PFIZER INC. | 4 | $66 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| Exact Sciences Corporation | 3 | $60 |
| Corcept Therapeutics | 2 | $43 |
| Abbott Laboratories | 2 | $37 |
| Lilly USA, LLC | 2 | $28 |
| Daiichi Sankyo Inc. | 1 | $21 |
Products named: Veozah, VRAYLAR, UBRELVY, SHINGRIX, Cologuard Collection Kit, Ozempic, Korlym, NURTEC ODT.
Industry payments across NJ — which companies pay providers there.
